Building a predictive model to identify clinical indicators for COVID-19 using machine learning method
Source check: Source checked. Not independent scientific confirmation.
Finding: An Explainable Boosting Machine selected COVID-19 indicators and a decision tree interpreted them in a case-control comparison with community-acquired pneumonia. The five indicator combinations achieved reported differentiation of 83.3–100%; the retrospective study calls for further verification.
Technology: Explainable boosting selects COVID-19 indicators; a decision tree interprets the case-control model.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Explainable boosting selects COVID-19 indicators; a decision tree interprets the case-control model.
- Test and result
- An explainable boosting model selects COVID-19 indicators and a decision tree interprets them in a COVID-19 versus community-acquired-pneumonia case-control dataset with a held-out test split.
- Limitation / still unknown
- The reported cohort or experimental dataset, comparator/reference and validation are specific to this case; conclusions remain bounded to that setting.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9037972/ · https://pubmed.ncbi.nlm.nih.gov/35469375/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.